Fresenius SE KGaA (XSWX:FRE) 6-Month Price Index: 0.88 (As of Jul. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:FRE Fresenius SE & Co KGaA XSWX:FRE
67 GF Score
Price CHF39.86
GF Value CHF33.05
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Fresenius SE KGaA 6-Month Price Index?

Fresenius SE KGaA XSWX:FRE 67 6-Month Price Index is 0.88 as of Jul. 28, 2026. GuruFocus rates XSWX:FRE with a GF Score™ of 67/100 and a GF Value™ of CHF33.05 (Modestly Overvalued). The stock has 5 warning signs investors should review.

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2026-07-28), Fresenius SE KGaA's 6-Month Price Index is 0.88.

Fresenius SE KGaA  (XSWX:FRE) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

Fresenius SE KGaA 6-Month Price Index Related Terms

XSWX:FRE vs HCA, THC, DVA: 6-Month Price Index Comparison

For the Medical Care Facilities subindustry, Fresenius SE KGaA's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XSWX:FRE
67GF Score
Fresenius SE & Co KGaA XSWX:FRE
6-Month Price Index is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius SE KGaA  (XSWX:FRE) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-Month Price Index →
What does a 6-Month Price Index of 0.88 mean?
Fresenius SE KGaA (XSWX:FRE) has a 6-Month Price Index of 0.88 as of Jul. 28, 2026. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Fresenius SE KGaA and its competitors.
Is Fresenius SE KGaA's 6-Month Price Index too high?
Fresenius SE KGaA's current 6-Month Price Index is 0.88. Overall, Fresenius SE KGaA has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's 6-Month Price Index compare to HCA and THC?
Fresenius SE KGaA's 6-Month Price Index of 0.88 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Price Index for a Healthcare Providers & Services company?
A good 6-Month Price Index depends on the Healthcare Providers & Services industry context. However, 6-Month Price Index should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Price Index mean?
A high 6-Month Price Index can signal that a stock is expensive relative to its fundamentals. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Fresenius SE KGaA and its competitors. Fresenius SE KGaA's current 6-Month Price Index is 0.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF33.05, compared to a current price of CHF39.86 — trading 20.6% above its estimated fair value. The current 6-Month Price Index is 0.88. Fresenius SE KGaA's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Price Index calculated?
6-Month Price Index is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current 6-Month Price Index is 0.88 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of CHF39.86 is trading 20.6% above its estimated GF Value™ of CHF33.05. GuruFocus considers Fresenius SE KGaA to be Modestly Overvalued.

Key valuation signals for XSWX:FRE:

  • 6-Month Price Index: 0.88
  • GF Value™: CHF33.05 vs. price of CHF39.86 (20.6% above fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
67GF Score

Get the complete analysis for XSWX:FRE

6-Month Price Index is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF39.86
Price
CHF33.05
GF Value